US2005136474A1PendingUtilityA1
Truncation SELEX method
Est. expiryJun 11, 2010(expired)· nominal 20-yr term from priority
G01N 2333/62C12N 15/1048G01N 2333/163G01N 33/76C07H 21/00G01N 2333/96436G01N 2333/575G01N 2333/503G01N 2333/966C40B 40/00C12Q 1/6811G01N 33/535C12Q 1/37G01N 33/56988G01N 2333/8125A61K 47/549C12N 2310/13G01N 33/532G01N 33/6842C07H 19/10G01N 33/531A61K 47/547C07K 14/001G01N 2333/974C12N 15/115G01N 2333/16G01N 2333/96433B82Y 5/00G01N 2333/9726F02B 2075/027G01N 33/68C12N 2310/53C12N 2310/322C12N 9/1276C07H 19/06G01N 2333/976G01N 2333/96455G01N 2333/96486
49
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
This invention is directed to a method for identifying nucleic acid ligands by the SELEX method wherein the participation of fixed sequences is eliminated or minimized.
Claims
exact text as granted — not AI-modified1 - 10 . (canceled)
11 . A method for identifying nucleic acid ligands of a target compound, said method comprising:
a) providing an candidate mixture of nucleic acids of differing sequences comprising randomized sequences, b) contacting said candidate mixture with a target under conditions favorable for binding between the target and members of the candidate mixture; c) partitioning those nucleic acids with higher affinity for the target from those nucleic acids with lesser affinity to the target to generate an enriched candidate mixture; d) ligating nucleic acids in said enriched candidate mixture to a 3′ primer binding site using RNA ligase to generate a ligation product; e) reverse transcribing the ligation product using the 3′ primer to generate cDNA; f) ligating the cDNA to a DNA oligonucleotide encoding the T7 promoter to generate a new dsDNA candidate mixture; g) transcribing the new candidate mixture to generate a new RNA candidate mixture; h) removing the 3′ primer binding site to yield a ligand-enriched mixture of nucleic acids, whereby nucleic acid ligands of the target compound may be identified.
12 . The method of claim 11 further comprising the step:
i) repeating steps b) through h) using the ligand enriched mixture of each successive repeat as many times as required to yield a desired level of ligand enrichment, whereby nucleic acid ligands of the target compound may be identified.
13 . The method of claim 11 wherein said candidate mixture is prepared from a template comprising a region of conserved sequence and a region of randomized sequence.
14 . The method of claim 13 , wherein said conserved sequence is a restriction site, and wherein said preparation comprises digesting the candidate mixture with a restriction enzyme and transcribing the digested candidate mixture.
15 . The method of claim 11 wherein said candidate mixture is prepared by providing a candidate mixture of nucleic acids of differing sequences comprising 3′-region of conserved sequence, 5′-region of conserved sequence, and a region of randomized sequence, and removing the 3′-region of conserved sequence and the 5′-region of conserved sequence by enzymatic digestion.
16 . The method of claim 15 , comprising:
a) providing an RNA candidate mixture comprising a 3′-region of conserved sequence, a 5′-region of conserved sequence and a region of randomized sequence; b) generating a cDNA candidate mixture from the RNA candidate mixture; c) transcribing the cDNA candidate mixture to generate an RNA transcript; d) removing the 5′ region of conserved sequence with RNaseH to generate digested RNA; e) reverse transcribing the digested RNA to generate cDNA; f) optionally ligating a 3′-primer binding site to the cDNA; g) ligating the generated cDNA to a DNA oligonucleotide encoding the T7 promoter-initiator to generate a ligation product; h) amplifying the ligation product to generate a new dsDNA candidate mixture lacking at least part of the 5′-region of conserved sequence; i) transcribing the dsDNA to generate a 5′-truncated transcript; and j) digesting the 3′end of the 5′-truncated transcript to generate a truncated RNA candidate mixture.
17 . The method of claim 16 , wherein the 3′-region of conserved sequence comprises a primer binding site.
18 . The method of claim 17 , wherein step d) further comprises removing the 3′ region of conserved sequence with RNaseH.Join the waitlist — get patent alerts
Track US2005136474A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.